Variant report
Variant | esv1809780 |
---|---|
Chromosome Location | chr13:51069443-51084150 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:51065916..51068221-chr13:51075145..51077143,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RNASEH2B-3 | chr13:51069312-51069605 | NONHSAT033856 |
2 | lnc-RNASEH2B-3 | chr13:51076948-51077016 | XLOC_010390 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000176124 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534469210 | chr13:51069595-51069596 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs139244559 | chr13:51069752-51069753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs548057463 | chr13:51069987-51069988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs138067170 | chr13:51075030-51075031 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs202114453 | chr13:51075075-51075076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201207605 | chr13:51075078-51075079 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149111933 | chr13:51075146-51075147 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs536917494 | chr13:51075155-51075156 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs111873278 | chr13:51075192-51075193 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs577007657 | chr13:51075201-51075202 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs541220532 | chr13:51075274-51075275 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs182285215 | chr13:51075310-51075311 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs138684753 | chr13:51075350-51075351 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs1630605 | chr13:51075385-51075386 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs563247185 | chr13:51075419-51075420 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs200340616 | chr13:51075421-51075422 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs532037188 | chr13:51075454-51075455 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs550165608 | chr13:51075491-51075492 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs565563324 | chr13:51075515-51075516 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs532643185 | chr13:51075577-51075578 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs12586080 | chr13:51075613-51075614 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs185680235 | chr13:51075616-51075617 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs531269665 | chr13:51075651-51075652 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs567010272 | chr13:51075679-51075680 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs548198459 | chr13:51075688-51075689 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs1753639 | chr13:51075736-51075737 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs564575878 | chr13:51075755-51075756 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs537445194 | chr13:51075785-51075786 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs201758 | chr13:51075852-51075853 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs577045310 | chr13:51075907-51075908 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs534553305 | chr13:51075989-51075990 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs141781657 | chr13:51076013-51076014 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs368907607 | chr13:51076040-51076041 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs201757 | chr13:51076070-51076071 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs563280453 | chr13:51076076-51076077 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs575170588 | chr13:51076121-51076122 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs377184123 | chr13:51076122-51076123 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs545777774 | chr13:51076183-51076184 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs369176331 | chr13:51076219-51076220 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs9526671 | chr13:51076380-51076381 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs386770930 | chr13:51076400-51076401 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs1327654 | chr13:51076402-51076403 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs146326135 | chr13:51076422-51076423 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs199547861 | chr13:51076437-51076438 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs1327653 | chr13:51076440-51076441 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs181013538 | chr13:51076444-51076445 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs200831513 | chr13:51076571-51076572 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs530838708 | chr13:51076650-51076651 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs377367976 | chr13:51076652-51076653 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs539164065 | chr13:51076756-51076757 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Trisomy | 24170809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Mental retardation | 17502991 | CNVD |
Retinoblastoma | 17502991 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Liposarcoma | 21253554 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cervical cancer | 21062161 | CNVD |
microdeletion syndrome | 19284877 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hereditary prostate cancer | 22028916 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Prostate cancer | 17217626 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21990379 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:51068600-51070000 | Enhancers | Dnd41 | blood |
2 | chr13:51075000-51075400 | Enhancers | Thymus | Thymus |
3 | chr13:51075000-51075800 | Enhancers | Primary monocytes fromperipheralblood | blood |
4 | chr13:51075000-51075800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
5 | chr13:51075000-51075800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr13:51075200-51075800 | Enhancers | K562 | blood |
7 | chr13:51075400-51083400 | Weak transcription | Thymus | Thymus |
8 | chr13:51075800-51084800 | Weak transcription | K562 | blood |
9 | chr13:51082800-51086000 | Weak transcription | Gastric | stomach |
10 | chr13:51083000-51083800 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
11 | chr13:51083200-51086200 | Enhancers | HepG2 | liver |
12 | chr13:51083400-51083600 | ZNF genes & repeats | Thymus | Thymus |
13 | chr13:51083400-51084200 | Enhancers | HSMM | muscle |
14 | chr13:51083400-51084400 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
15 | chr13:51083400-51084400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
16 | chr13:51083400-51084400 | Enhancers | NH-A | brain |
17 | chr13:51083400-51084400 | Enhancers | Osteobl | bone |
18 | chr13:51083400-51085800 | Enhancers | Dnd41 | blood |
19 | chr13:51083600-51084400 | Weak transcription | Thymus | Thymus |
20 | chr13:51084000-51084200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
21 | chr13:51084000-51084200 | Enhancers | Spleen | Spleen |
22 | chr13:51084000-51084200 | Enhancers | HSMMtube | muscle |
23 | chr13:51084000-51084400 | Enhancers | HMEC | breast |
24 | chr13:51084000-51084400 | Enhancers | NHDF-Ad | bronchial |
25 | chr13:51084000-51084800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
26 | chr13:51084000-51086400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |